Lyudmila A. Strozenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lyudmila A. Strozenko has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
- Yuriy F. Lobanov
Алтайский государственный медицинский университет
27 shared publications - Evgeniy V. Skudarnov
Altai State Medical University
14 shared publications - Viktor S. Ponomarev
Алтайский государственный медицинский университет
13 shared publications - Nataliya M. Micheeva
Altai State Medical University
11 shared publications - Nikolay A. Dorokhov
Altai State Medical University
10 shared publications - Dmitriy Yu. Latyshev
Алтайский Государственный Медицинский Университет, г. Барнаул, Российская Федерация
9 shared publications
Latest Publications
- Open Access
- 25 June 2026
- Published by National Medical Research Center for Childrens Health in M.Ya. Studenikin Russian Pediatric Journal
- Vol. 1 (2) , 104-109
Evaluation of the Efficacy, Safety and Adherence to Treatment with the Use of Suspension and Tablet Form of Furazidin in Preschool Children with Urinary Tract Infection
Introduction. Lower urinary tract infections are a leading cause of morbidity in preschool-aged children. Standard solid dosage forms of furazidin (tablets, capsules) often reduce treatment adherence in children aged 3–7 years due to swallowing difficulties and a bitter taste. Aim: of the work is a comparative assessment of the efficacy, safety and adherence to therapy when using the developed extemporaneous suspension of furazidin (50 mg/5 ml) in comparison with the tablet form in children with cystitis. Materials and methods. A prospective, open, comparative study was conducted involving 60 children (3–7 years) with lower urinary tract infections who received outpatient treatment. Two groups were formed: the study group (n=30) received furazidin suspension; the comparison group (n=30) received furazidin tablets at a dose of 5 mg/kg/day for 7–10 days. The study assessed efficacy, the incidence of adverse reactions, and adherence to treatment. Results. By day 3, dysuria relief was achieved in 90% of children in the treatment group versus 73.3% in the comparison group (p 0.05). Adherence to treatment (>80% of doses) in the suspension group was 100% versus 83.3% in the tablet group (p Conclusion. Furazidin suspension is an effective, safer, and more compliant dosage form for the treatment of uncomplicated urinary tract infections in children aged 3–7 years compared to tablets. It provides precise dosing, is easy to administer, and is less likely to cause dyspeptic symptoms. It can be recommended for wider use in pediatric practice.
- 25 June 2026
- Published by National Medical Research Center for Childrens Health in M.Ya. Studenikin Russian Pediatric Journal
- Vol. 1 (2) , 104-109
Open AccessEvaluation of the Efficacy, Safety and Adherence to Treatment with the Use of Suspension and Tablet Form of Furazidin in Preschool Children with Urinary Tract Infection
Introduction. Lower urinary tract infections are a leading cause of morbidity in preschool-aged children. Standard solid dosage forms of furazidin (tablets, capsules) often reduce treatment adherence in children aged 3–7 years due to swallowing difficulties and a bitter taste. Aim: of the work is a comparative assessment of the efficacy, safety and adherence to therapy when using the developed extemporaneous suspension of furazidin (50 mg/5 ml) in comparison with the tablet form in children with cystitis. Materials and methods. A prospective, open, comparative study was conducted involving 60 children (3–7 years) with lower urinary tract infections who received outpatient treatment. Two groups were formed: the study group (n=30) received furazidin suspension; the comparison group (n=30) received furazidin tablets at a dose of 5 mg/kg/day for 7–10 days. The study assessed efficacy, the incidence of adverse reactions, and adherence to treatment. Results. By day 3, dysuria relief was achieved in 90% of children in the treatment group versus 73.3% in the comparison group (p 0.05). Adherence to treatment (>80% of doses) in the suspension group was 100% versus 83.3% in the tablet group (p Conclusion. Furazidin suspension is an effective, safer, and more compliant dosage form for the treatment of uncomplicated urinary tract infections in children aged 3–7 years compared to tablets. It provides precise dosing, is easy to administer, and is less likely to cause dyspeptic symptoms. It can be recommended for wider use in pediatric practice.
- Open Access
- 27 March 2026
- Published by National Medical Research Center for Childrens Health in M.Ya. Studenikin Russian Pediatric Journal
- Vol. 1 (1) , 38-44
Quality of life in children with hemorrhagic syndrome, taking into account the level of homocysteine in blood plasma
Introduction. The quality of life is an integral characteristic of the vital activity, which covers in patients the social, physical, and psychological functioning. The quality of life is defined as a person’s individual relationship to their position in life (culture, values, plans and goals in this person, opportunities and degree of disorder). Aim: to determine changes in the parameters of the quality of life of children with hemorrhagic syndrome, taking into account the level of homocysteine in blood plasma. Materials and methods. There were examined ninety seven children aged of 13–17 years. The main group consisted of 30 adolescents with clinical manifestations of hemorrhagic syndrome. The control group consisted of 67 children without signs of bleeding. The children of both groups were comparable in gender and age. The quality of life was assessed using a valid randomized questionnaire, the Pediatric Quality of Life Questionnaire PedsQL4.0 for adolescents. There were assessed following parameters of functioning: physical, emotional, social, school and psychosocial health. Based on the data obtained, the total score was calculated. All the data received has been processed statistically. Results. The highest indicators of the quality of life were obtained in children of the control group on the scales of social and physical functioning. The indicators of quality of life in children with hemorrhagic syndrome on the background of hyperhomocysteinemia had lower scores on the scales of physical functioning (96.25 points), school functioning (84.16 points), psychosocial health (84.40 points) and overall score (86.70 points) when compared with children with hemorrhagic syndrome, whose plasma homocysteine levels was within the normal range. The maximum difference in scores when comparing children of both groups was found on the scale of social functioning (13.3 points), followed by psychosocial health (12.0 points) and emotional functioning (11.8 points). Conclusion. According to all studied parameters the quality of life in children without hemorrhagic manifestations is significantly higher. To prevent hyperhomocysteinemia and increase QOL in children with bleeding symptoms, rational folate-vitamin correction is advisable. Contribution: Strozenko L.А., Lobanov Yu.F. — concept and design of the study; Ponomarev V.S., Sanina О.О. — collection and processing of the material; Ponomarev V.S., Strozenko L.А. — statistical processing of the material; Ponomarev V.S., Strozenko L.А. — writing the text; Lobanov Yu.F., Skudarnov E.V. — editing the text. All co-authors — approval of the final version of the article, responsibility for the integrity of all parts of the article. Acknowledgments. The study had no sponsorship. Conflict of interest. The authors declare no conflict of interest. Received: January 23, 2026Accepted: February 10, 2026Published: February 27, 2026
- 27 March 2026
- Published by National Medical Research Center for Childrens Health in M.Ya. Studenikin Russian Pediatric Journal
- Vol. 1 (1) , 38-44
Open AccessQuality of life in children with hemorrhagic syndrome, taking into account the level of homocysteine in blood plasma
Introduction. The quality of life is an integral characteristic of the vital activity, which covers in patients the social, physical, and psychological functioning. The quality of life is defined as a person’s individual relationship to their position in life (culture, values, plans and goals in this person, opportunities and degree of disorder). Aim: to determine changes in the parameters of the quality of life of children with hemorrhagic syndrome, taking into account the level of homocysteine in blood plasma. Materials and methods. There were examined ninety seven children aged of 13–17 years. The main group consisted of 30 adolescents with clinical manifestations of hemorrhagic syndrome. The control group consisted of 67 children without signs of bleeding. The children of both groups were comparable in gender and age. The quality of life was assessed using a valid randomized questionnaire, the Pediatric Quality of Life Questionnaire PedsQL4.0 for adolescents. There were assessed following parameters of functioning: physical, emotional, social, school and psychosocial health. Based on the data obtained, the total score was calculated. All the data received has been processed statistically. Results. The highest indicators of the quality of life were obtained in children of the control group on the scales of social and physical functioning. The indicators of quality of life in children with hemorrhagic syndrome on the background of hyperhomocysteinemia had lower scores on the scales of physical functioning (96.25 points), school functioning (84.16 points), psychosocial health (84.40 points) and overall score (86.70 points) when compared with children with hemorrhagic syndrome, whose plasma homocysteine levels was within the normal range. The maximum difference in scores when comparing children of both groups was found on the scale of social functioning (13.3 points), followed by psychosocial health (12.0 points) and emotional functioning (11.8 points). Conclusion. According to all studied parameters the quality of life in children without hemorrhagic manifestations is significantly higher. To prevent hyperhomocysteinemia and increase QOL in children with bleeding symptoms, rational folate-vitamin correction is advisable. Contribution: Strozenko L.А., Lobanov Yu.F. — concept and design of the study; Ponomarev V.S., Sanina О.О. — collection and processing of the material; Ponomarev V.S., Strozenko L.А. — statistical processing of the material; Ponomarev V.S., Strozenko L.А. — writing the text; Lobanov Yu.F., Skudarnov E.V. — editing the text. All co-authors — approval of the final version of the article, responsibility for the integrity of all parts of the article. Acknowledgments. The study had no sponsorship. Conflict of interest. The authors declare no conflict of interest. Received: January 23, 2026Accepted: February 10, 2026Published: February 27, 2026
- Open Access
- 1 January 2026
- Published by NP Rusmedical Group in Doctor.Ru
- Vol. 25 (5)
Predicting Thrombotic Complications in Children with Migraine
Aim. To assess the prognostic significance of persistent and transient thrombogenic risk factors in children with migraine to determine the likelihood of thrombotic complications and the subsequent classification of patients into risk groups. Design. Retrospective study. Materials and methods. The study group included 54 patients aged 7 to 18 years with clinical manifestations of migraine. The control group consisted of 115 children without signs of neurological or hematological pathology. Patients in both groups were comparable in terms of age and sex. A retrospective analysis of outpatient medical records was performed to extract data on the child health status. Molecular genetic testing was conducted to identify polymorphisms of genes related to the hemostatic system and folate cycle enzymes, and plasma homocysteine and folate levels were determined. The major neck vessels were assessed using duplex scanning. Statistical analysis was performed with MedCalc software using Fisher's exact test, χ2 with Yates' correction, and calculation of the odds ratio (95% confidence interval). The prognostic model was developed using the Wald — Genkin — Gubler method. Results. Сhildren with migraine had a statistically significant burdened family history of thrombosis (p < 0.001). Clinical manifestations of hemorrhagic syndrome and instrumentally verified pathological tortuosity of the major neck vessels also significantly prevailed in the study group (p < 0.001). Genetic analysis revealed that patients with migraine were statistically significantly more likely to be carriers of the homozygous 677T/T genotype of the MTHFR gene than children in the control group (p < 0.001). Elevated homocysteine levels and decreased plasma folate concentrations were significantly more common in the study group (p < 0.001). Moreover, complex combinations of three and four genes were significantly more frequent in children in the study group (p = 0.025 and p = 0.036, respectively). Based on the calculation of the diagnostic coefficients of the most informative factors, the threshold values for assessing the likelihood of thrombotic complications were determined. The threshold for inclusion in the risk group was 13 points or more. Conclusion. The developed prognostic scale is characterized by high specificity and positive predictive value with moderate sensitivity. The model’s statistical parameters ensure a high level of diagnostic accuracy with an error rate not exceeding 5%. Implementing this prognostic scale in pediatric practice will enable the timely identification of children with migraine who are at high risk of developing thrombotic complications (including those with concomitant hemorrhagic manifestations) for subsequent in-depth examination and personalized primary thromboprophylaxis. Keywords: children, migraine, thrombosis, folate cycle.
- 1 January 2026
- Published by NP Rusmedical Group in Doctor.Ru
- Vol. 25 (5)
Open AccessPredicting Thrombotic Complications in Children with Migraine
Aim. To assess the prognostic significance of persistent and transient thrombogenic risk factors in children with migraine to determine the likelihood of thrombotic complications and the subsequent classification of patients into risk groups. Design. Retrospective study. Materials and methods. The study group included 54 patients aged 7 to 18 years with clinical manifestations of migraine. The control group consisted of 115 children without signs of neurological or hematological pathology. Patients in both groups were comparable in terms of age and sex. A retrospective analysis of outpatient medical records was performed to extract data on the child health status. Molecular genetic testing was conducted to identify polymorphisms of genes related to the hemostatic system and folate cycle enzymes, and plasma homocysteine and folate levels were determined. The major neck vessels were assessed using duplex scanning. Statistical analysis was performed with MedCalc software using Fisher's exact test, χ2 with Yates' correction, and calculation of the odds ratio (95% confidence interval). The prognostic model was developed using the Wald — Genkin — Gubler method. Results. Сhildren with migraine had a statistically significant burdened family history of thrombosis (p < 0.001). Clinical manifestations of hemorrhagic syndrome and instrumentally verified pathological tortuosity of the major neck vessels also significantly prevailed in the study group (p < 0.001). Genetic analysis revealed that patients with migraine were statistically significantly more likely to be carriers of the homozygous 677T/T genotype of the MTHFR gene than children in the control group (p < 0.001). Elevated homocysteine levels and decreased plasma folate concentrations were significantly more common in the study group (p < 0.001). Moreover, complex combinations of three and four genes were significantly more frequent in children in the study group (p = 0.025 and p = 0.036, respectively). Based on the calculation of the diagnostic coefficients of the most informative factors, the threshold values for assessing the likelihood of thrombotic complications were determined. The threshold for inclusion in the risk group was 13 points or more. Conclusion. The developed prognostic scale is characterized by high specificity and positive predictive value with moderate sensitivity. The model’s statistical parameters ensure a high level of diagnostic accuracy with an error rate not exceeding 5%. Implementing this prognostic scale in pediatric practice will enable the timely identification of children with migraine who are at high risk of developing thrombotic complications (including those with concomitant hemorrhagic manifestations) for subsequent in-depth examination and personalized primary thromboprophylaxis. Keywords: children, migraine, thrombosis, folate cycle.
- 1 January 2026
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 38 (3) , 106-111
X-LINKED CENTRONUCLEAR MYOPATHY: A CLINICAL CASE IN A PEDIATRICIAN'S PRACTICE
X-linked myotubular myopathy (X-МTM) is a serious and potentially fatal myopathy resulting from a mutation in the myotubularin (MTM1) gene. The primary clinical features include widespread muscle weakness, early-onset hypotension, and respiratory failure, along with various associated conditions that frequently lead to mortality. The authors present a clinical case involving a 3.5-year-old boy diagnosed with X-linked myotubular myopathy. This patient was monitored from the age of 11 months, with the diagnosis confirmed at 1.4 years through whole-genome sequencing. A novel nonsense mutation in exon 7 of the MTM1 gene was discovered, which is responsible for the onset of X-linked myotubular myopathy. The mutation in the myotubularin (MTM1) gene disrupts the normal development and functioning of myocytes, resulting in a distinct triad of symptoms: widespread muscle weakness, neonatal hypotonia, and respiratory failure. Furthermore, several additional features typical of X-linked myotubular myopathy have been identified: physical characteristics (such as dolichocephaly, arachnodactyly, elongated limbs, and tall stature), cryptorchidism, joint contractures, dysphagia accompanied by weakness in the swallowing muscles, psychomotor retardation, peliosis hepatis, and progressive ophthalmoplegia. X-linked myotubular myopathy can result in severe, life-threatening complications, highlighting the critical need for early diagnosis and intervention. Given the infrequency of this condition, the potential for de novo mutations in the gene, and the extensive differential diagnosis that includes both myopathies and bronchopulmonary disorders, it is vital to gather clinical data on X-linked myotubular myopathy. Consequently, it is imperative to engage clinicians and establish protocols for the early detection of myopathy within the first year of life to reduce the risks associated with delayed diagnosis and management errors.
- 1 January 2026
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 38 (3) , 106-111
X-LINKED CENTRONUCLEAR MYOPATHY: A CLINICAL CASE IN A PEDIATRICIAN'S PRACTICE
X-linked myotubular myopathy (X-МTM) is a serious and potentially fatal myopathy resulting from a mutation in the myotubularin (MTM1) gene. The primary clinical features include widespread muscle weakness, early-onset hypotension, and respiratory failure, along with various associated conditions that frequently lead to mortality. The authors present a clinical case involving a 3.5-year-old boy diagnosed with X-linked myotubular myopathy. This patient was monitored from the age of 11 months, with the diagnosis confirmed at 1.4 years through whole-genome sequencing. A novel nonsense mutation in exon 7 of the MTM1 gene was discovered, which is responsible for the onset of X-linked myotubular myopathy. The mutation in the myotubularin (MTM1) gene disrupts the normal development and functioning of myocytes, resulting in a distinct triad of symptoms: widespread muscle weakness, neonatal hypotonia, and respiratory failure. Furthermore, several additional features typical of X-linked myotubular myopathy have been identified: physical characteristics (such as dolichocephaly, arachnodactyly, elongated limbs, and tall stature), cryptorchidism, joint contractures, dysphagia accompanied by weakness in the swallowing muscles, psychomotor retardation, peliosis hepatis, and progressive ophthalmoplegia. X-linked myotubular myopathy can result in severe, life-threatening complications, highlighting the critical need for early diagnosis and intervention. Given the infrequency of this condition, the potential for de novo mutations in the gene, and the extensive differential diagnosis that includes both myopathies and bronchopulmonary disorders, it is vital to gather clinical data on X-linked myotubular myopathy. Consequently, it is imperative to engage clinicians and establish protocols for the early detection of myopathy within the first year of life to reduce the risks associated with delayed diagnosis and management errors.
- Open Access
- 22 June 2025
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 2,p. 85-88
Etiology of community-acquired pneumonia in children of Barnaul
The results of a survey of 1,118 Barnaul children aged 0 to 17 to determine the etiological structure of community-acquired pneumonia pathogens from January to October 2024 are presented. Mycoplasma pneumoniae was the predominant pathogen 36%, less often COVID-19. The clinical picture of mycoplasma pneumonia in children is atypical. Etiotropic therapy brings good results.
- 22 June 2025
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 2,p. 85-88
Open AccessEtiology of community-acquired pneumonia in children of Barnaul
The results of a survey of 1,118 Barnaul children aged 0 to 17 to determine the etiological structure of community-acquired pneumonia pathogens from January to October 2024 are presented. Mycoplasma pneumoniae was the predominant pathogen 36%, less often COVID-19. The clinical picture of mycoplasma pneumonia in children is atypical. Etiotropic therapy brings good results.
- 11 February 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (1) , 47-52
The role of genetic polymorphisms in folate metabolism genes in the manifestation of migraine in children
Objective. To assess the role of genetic polymorphisms in folate metabolism enzyme genes in the manifestation of migraine in children. Material and Methods. The study included 54 children aged 7 to 18 years with clinical manifestations of migraine. The control group consisted of 115 children without neurological disorders. Genetic analysis of four polymorphic variants of folate cycle enzyme genes was conducted: MTHFR: 677C>T (A223V C677T, rs1801133); MTHFR: 1298A>C (E429A A1298C, rs1801131); MTR: 2756A>G (A2756G, rs1805087); MTRR: 66A>G (A66G, rs1801394). In addition to genetic testing, data collection included patient complaints, medical and family histories, clinical examinations, determination of vitamin B levels (B6, B9, B12), and plasma homocysteine levels. The therapeutic effect of Cortexin (10 mg intramuscularly once daily) on the course of migraine in children was also assessed. Results. The rare homozygous 677TT genotype of the MTHFR gene was significantly more frequent in the study group (p=0.043), while the heterozygous 1298AC genotype of the MTHFR gene and the common homozygous 66AA genotype of the MTRR gene were more prevalent in the control group (p<0.05). Furthermore, levels of B vitamins (B6, B9, B12) and plasma homocysteine were measured in both groups. Children in the study group received a 10-day course of Cortexin. Conclusion. Patients with migraine showed a higher prevalence of the rare homozygous 677TT genotype of the MTHFR gene, which leads to elevated plasma homocysteine levels, often associated with latent folate deficiency. The use of «Cortexin» significantly improved the patients’ condition, reducing complaints of headaches, fatigue, and emotional instability.
- 11 February 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (1) , 47-52
The role of genetic polymorphisms in folate metabolism genes in the manifestation of migraine in children
Objective. To assess the role of genetic polymorphisms in folate metabolism enzyme genes in the manifestation of migraine in children. Material and Methods. The study included 54 children aged 7 to 18 years with clinical manifestations of migraine. The control group consisted of 115 children without neurological disorders. Genetic analysis of four polymorphic variants of folate cycle enzyme genes was conducted: MTHFR: 677C>T (A223V C677T, rs1801133); MTHFR: 1298A>C (E429A A1298C, rs1801131); MTR: 2756A>G (A2756G, rs1805087); MTRR: 66A>G (A66G, rs1801394). In addition to genetic testing, data collection included patient complaints, medical and family histories, clinical examinations, determination of vitamin B levels (B6, B9, B12), and plasma homocysteine levels. The therapeutic effect of Cortexin (10 mg intramuscularly once daily) on the course of migraine in children was also assessed. Results. The rare homozygous 677TT genotype of the MTHFR gene was significantly more frequent in the study group (p=0.043), while the heterozygous 1298AC genotype of the MTHFR gene and the common homozygous 66AA genotype of the MTRR gene were more prevalent in the control group (p<0.05). Furthermore, levels of B vitamins (B6, B9, B12) and plasma homocysteine were measured in both groups. Children in the study group received a 10-day course of Cortexin. Conclusion. Patients with migraine showed a higher prevalence of the rare homozygous 677TT genotype of the MTHFR gene, which leads to elevated plasma homocysteine levels, often associated with latent folate deficiency. The use of «Cortexin» significantly improved the patients’ condition, reducing complaints of headaches, fatigue, and emotional instability.
- Open Access
- 1 January 2025
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 37 (3) , 103-112
CLINICAL AND PHARMACOLOGICAL STRATEGIES FOR DIURETIC USE IN PEDIATRIC PRACTICE
Despite the fact that there is long-term experience in the use of diuretics in medicine, the use of diuretics in children is complicated by an insufficient scientific database on the efficacy and safety of this group of drugs, as well as the peculiarities of pharmacokinetics in children. There is only limited information in the literature on clinical studies of diuretics in pediatric practice, as a result of which most pediatricians are forced to extrapolate the data obtained in the treatment of adult patients to children and adolescents. This article provides data that include the mechanism of action, the pharmacokinetics of various groups of diuretics, and approaches for use in pediatric patients with certain conditions and diseases.
- 1 January 2025
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 37 (3) , 103-112
Open AccessCLINICAL AND PHARMACOLOGICAL STRATEGIES FOR DIURETIC USE IN PEDIATRIC PRACTICE
Despite the fact that there is long-term experience in the use of diuretics in medicine, the use of diuretics in children is complicated by an insufficient scientific database on the efficacy and safety of this group of drugs, as well as the peculiarities of pharmacokinetics in children. There is only limited information in the literature on clinical studies of diuretics in pediatric practice, as a result of which most pediatricians are forced to extrapolate the data obtained in the treatment of adult patients to children and adolescents. This article provides data that include the mechanism of action, the pharmacokinetics of various groups of diuretics, and approaches for use in pediatric patients with certain conditions and diseases.
- Open Access
- 1 January 2025
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 37 (3) , 12-18
RISK FACTORS FOR INTRAVENTRICULAR HEMORRHAGE IN TERM NEWBORNS
Introduction. A pressing issue in neonatology is the study of the causes, pathogenesis, and clinical course of intraventricular hemorrhages (IVH) in newborns. The problem of IVH is significant due to its association with perinatal brain injuries. Objective. To study risk predictors for the development of IVH in full-term newborns. Materials and Methods. This work is based on the results of a retrospective analysis of the medical histories of 68 newborns with grade 2 IVH who were hospitalized in the neonatal pathology department during 2017-2018 at the Children's City Clinical Hospital No. 7, Barnaul. Results. The analysis confirmed the involvement of the main risk predictors for the development of grade 2 IVH in term newborns: perinatal factors, birth trauma, and hemorrhagic complications, a deficiency of vitamin K-dependent coagulation factors. Conclusion. IVH in term newborns is a polyetiological condition that requires a multidisciplinary approach. Risk predictors for the development of IVH in children include maternal extragenital diseases, pregnancy pathology, delivery issues, and neonatal factors.
- 1 January 2025
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 37 (3) , 12-18
Open AccessRISK FACTORS FOR INTRAVENTRICULAR HEMORRHAGE IN TERM NEWBORNS
Introduction. A pressing issue in neonatology is the study of the causes, pathogenesis, and clinical course of intraventricular hemorrhages (IVH) in newborns. The problem of IVH is significant due to its association with perinatal brain injuries. Objective. To study risk predictors for the development of IVH in full-term newborns. Materials and Methods. This work is based on the results of a retrospective analysis of the medical histories of 68 newborns with grade 2 IVH who were hospitalized in the neonatal pathology department during 2017-2018 at the Children's City Clinical Hospital No. 7, Barnaul. Results. The analysis confirmed the involvement of the main risk predictors for the development of grade 2 IVH in term newborns: perinatal factors, birth trauma, and hemorrhagic complications, a deficiency of vitamin K-dependent coagulation factors. Conclusion. IVH in term newborns is a polyetiological condition that requires a multidisciplinary approach. Risk predictors for the development of IVH in children include maternal extragenital diseases, pregnancy pathology, delivery issues, and neonatal factors.
- Open Access
- 1 January 2025
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 37 (3) , 42-47
CLINICAL COURSE OF EROSIVE GASTROESOPHAGEAL REFLUX DISEASE IN SCHOOL-AGE CHILDREN: CURRENT PERSPECTIVES
Introduction. In children, the manifestations of gastroesophageal reflux disease (GERD) can vary from an asymptomatic course or nonspecific symptoms, such as irritability in infants, refusal to eat, anorexia, cough, to more specific ones, such as heartburn, regurgitation, abdominal pain in older children, which significantly complicates the diagnosis. Symptoms in a child may indicate the need for examination or treatment of GERD, but the reliability of these clinical manifestations is not always clear, which can lead to unjustified diagnostic interventions and excessive or insufficient therapy. Objective. To study the features of the clinical course of the erosive form of gastroesophageal reflux disease in school-age children. Materials and Methods. Included 98 school-age children with erosive GERD, aged 7 to 18 years old, (mean age 11.4±2.1 years, of which boys – 71, girls – 27). The main inclusion criteria were: primary visit with symptoms of dyspepsia; the presence of erosive changes in the esophagus according to fibrogastroduodenoscopy. The comparison group consisted of 30 children with non-reperfusion GERD (mean age 12.7±1.8 years, boys – 11, girls – 19). The main inclusion criteria were: the presence of heartburn at least once a week over the last 3 months; the absence of erosive changes in the esophagus according to fibrogastroscopy. A comparative evaluation of the clinical manifestations of the disease was carried out. Results. Only 33.6% of children with erosive GERD complain of heartburn. Heartburn is more often observed in older (45.4%) than in younger (23.6%) schoolchildren. Abdominal pain is observed in 96.9%, belching in 43.8%, and nausea in 37.7% of the examined. In 11.2% of the children, periodic episodes of vomiting are observed and in 7.1%, halitosis. The clinical manifestations of the disease do not depend on the severity of erosive changes in the esophagus. The overlap with diarrhea-IBS was detected in 16.3%, and IBS with constipation /functional constipation in 10.2%, in addition, the overlap with postprandial distress syndrome is observed in 5.1% of children.
- 1 January 2025
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 37 (3) , 42-47
Open AccessCLINICAL COURSE OF EROSIVE GASTROESOPHAGEAL REFLUX DISEASE IN SCHOOL-AGE CHILDREN: CURRENT PERSPECTIVES
Introduction. In children, the manifestations of gastroesophageal reflux disease (GERD) can vary from an asymptomatic course or nonspecific symptoms, such as irritability in infants, refusal to eat, anorexia, cough, to more specific ones, such as heartburn, regurgitation, abdominal pain in older children, which significantly complicates the diagnosis. Symptoms in a child may indicate the need for examination or treatment of GERD, but the reliability of these clinical manifestations is not always clear, which can lead to unjustified diagnostic interventions and excessive or insufficient therapy. Objective. To study the features of the clinical course of the erosive form of gastroesophageal reflux disease in school-age children. Materials and Methods. Included 98 school-age children with erosive GERD, aged 7 to 18 years old, (mean age 11.4±2.1 years, of which boys – 71, girls – 27). The main inclusion criteria were: primary visit with symptoms of dyspepsia; the presence of erosive changes in the esophagus according to fibrogastroduodenoscopy. The comparison group consisted of 30 children with non-reperfusion GERD (mean age 12.7±1.8 years, boys – 11, girls – 19). The main inclusion criteria were: the presence of heartburn at least once a week over the last 3 months; the absence of erosive changes in the esophagus according to fibrogastroscopy. A comparative evaluation of the clinical manifestations of the disease was carried out. Results. Only 33.6% of children with erosive GERD complain of heartburn. Heartburn is more often observed in older (45.4%) than in younger (23.6%) schoolchildren. Abdominal pain is observed in 96.9%, belching in 43.8%, and nausea in 37.7% of the examined. In 11.2% of the children, periodic episodes of vomiting are observed and in 7.1%, halitosis. The clinical manifestations of the disease do not depend on the severity of erosive changes in the esophagus. The overlap with diarrhea-IBS was detected in 16.3%, and IBS with constipation /functional constipation in 10.2%, in addition, the overlap with postprandial distress syndrome is observed in 5.1% of children.
- Open Access
- 1 January 2025
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №1 2025,p. 33
PREVALENCE AND DETECTABILITY OF RISK FACTORS FOR ARTERIAL HYPO- AND HYPERTENSION IN SENIOR STUDENTS OF THE ALTAI STATE MEDICAL UNIVERSITY, BARNAUL
- 1 January 2025
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №1 2025,p. 33
Open AccessPREVALENCE AND DETECTABILITY OF RISK FACTORS FOR ARTERIAL HYPO- AND HYPERTENSION IN SENIOR STUDENTS OF THE ALTAI STATE MEDICAL UNIVERSITY, BARNAUL